Sign in

CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
operating
EIN
621765329
Phone
615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
  1. 4 Open-market buy Director bought 678 shares at an average $2.31 ($1,569)
  2. 4 Open-market buy Director bought 1,057 shares at an average $2.31 ($2,446)
  3. 4 Open-market buy Director bought 2,125 shares at an average $2.31 ($4,912)
  4. 4 Open-market buy Director bought 3,566 shares at an average $2.31 ($8,241)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Other disposition SVP and Chief Development Off. disposed of 33,500 shares (other)
  7. 4 Open-market buy Director bought 533 shares at an average $2.04 ($1,088)
  8. 4 Open-market buy Director bought 797 shares at an average $2.04 ($1,628)
  9. 4 Open-market buy Director bought 2,717 shares at an average $2.04 ($5,548)
  10. 4 Open-market buy Director bought 1,623 shares at an average $2.04 ($3,314)
  11. 4 Open-market buy Director bought 480 shares at an average $2.30 ($1,103)
  12. 4 Open-market buy Director bought 718 shares at an average $2.30 ($1,650)
  13. 4 Open-market buy Director bought 1,441 shares at an average $2.30 ($3,311)
  14. 4 Open-market buy Director bought 2,407 shares at an average $2.30 ($5,531)
  15. 4 Open-market buy Director bought 214 shares at an average $2.61 ($559)
  16. 4 Open-market buy Director bought 318 shares at an average $2.61 ($830)
  17. 4 Open-market buy Director bought 641 shares at an average $2.61 ($1,673)
  18. 4 Open-market buy Director bought 1,069 shares at an average $2.61 ($2,791)
  19. 4 Other disposition Sr VP/Chief Commercial Officer disposed of 15,000 shares (other)
  20. 4 Grant or award Director acquired 1,000 shares (grant or award)

Page 9 of 26 · 512 filings